Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hemostatic Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112500304A reveals pressurized alkaline hydrolysis for 6-aminocaproic acid. Achieves high purity and yield with reduced processing time for supply chain efficiency.
Novel oxidation-ammonolysis method improves yield to 70%, reducing costs for pharmaceutical intermediates manufacturing and ensuring supply chain stability.
Novel two-step synthesis of aminomethylbenzoic acid from p-toluic acid ensures >99.9% purity and scalable production for pharmaceutical intermediates.
Novel Diels-Alder route for high-purity tranexamic acid. Reduces heavy metal residues and improves yield for API manufacturing.
Discover a safe, cyanide-free synthesis for aminomethylbenzoic acid. High-yield pharmaceutical intermediate manufacturing with reduced environmental impact.
Patent CN114014768A details a barium-free continuous flow synthesis for high-purity tranexamic acid, offering significant cost reduction in API manufacturing and enhanced supply chain safety.